Beneficial of adding Tocilizumab to standard care in critical forms of Covid-19 pneumonia: Study on paired series.

MLA

Trifi, Ahlem, et al. “Beneficial of Adding Tocilizumab to Standard Care in Critical Forms of Covid-19 Pneumonia: Study on Paired Series.” La Tunisie Medicale, vol. 100, no. 4, Jan. 2022, pp. 309–12. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=36155902&authtype=sso&custid=ns315887.

APA

Trifi, A., Abdennebi, C., Mehdi, A., Ben Romdhane, K., Blel, Y., Daly, F., Zakhama, B., Mestiri, T., Abdellatif, S., & Ben Lakhal, S. (2022). Beneficial of adding Tocilizumab to standard care in critical forms of Covid-19 pneumonia: Study on paired series. La Tunisie Medicale, 100(4), 309–312.

Chicago

Trifi, Ahlem, Cyrine Abdennebi, Asma Mehdi, Kais Ben Romdhane, Youssef Blel, Foued Daly, Boubaker Zakhama, Taher Mestiri, Sami Abdellatif, and Salah Ben Lakhal. 2022. “Beneficial of Adding Tocilizumab to Standard Care in Critical Forms of Covid-19 Pneumonia: Study on Paired Series.” La Tunisie Medicale 100 (4): 309–12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=36155902&authtype=sso&custid=ns315887.